Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of 24-hour vs 72-hour octreotide infusion after
variceal banding in cirrhotic patients with bleeding esophageal varices.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of South Carolina
Collaborators:
Ohio State University University of Florida Health University of Texas Southwestern Medical Center